Clicky

Kopran Limited(524280)

Description: Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers finished dosage forms, including tablets, capsules, dry powder, suspension, and injectable in various therapeutic areas comprising cardiovascular, gastrointestinal, pain management, oncology, anti-allergic, central nervous system, erectile dysfunction, and others, as well as antibiotics, anti-diabetic, respiratory, anthelmentics, antiprotozoals, and antipeptic ulcer and gut. It also provides active pharmaceutical ingredients in the categories of anti-hypertensive, macrolide, neuromodulator, sterile cephalosporins, carbapenems, anti-acne, anti-ulcerant, anti-depressent, anti-infective, urological, and anti-thrombotic. The company was incorporated in 1958 and is headquartered in Mumbai, India.


Keywords: Pharmaceutical Medication Pharmacy Antibiotics Active Pharmaceutical Ingredients Pain Management Erectile Dysfunction Pharmaceutics Carbapenem Cephalosporin Macrolide

Home Page: www.kopran.com

Parijat House
Mumbai, 400018
India
Phone: 91 22 4366 1111


Officers

Name Title
Mr. Surendra Shrikrishna Somani Exec. Vice Chairman
Mr. Basant Kumar Soni Chief Financial Officer
Mr. Sunil Sodhani Company Sec. & Compliance Officer
Mr. Ajit Jain Chief Operating Officer
Chandra M. Singhi Director
Ahren A. Rodrigues Company Sec. of Kopran Laboratories Limited
Ms. Vandana Somani Director
Rakesh Doshi Director
K. B. Shetty Chief Financial Officer of Kopran Laboratories Limited

Exchange: BSE

Country: IN

Currency: Indian Rupee (INR)

Forward PE: 0
Trailing PE: 12.8711
Price-to-Book MRQ: 2.4493
Price-to-Sales TTM: 1.2653
IPO Date:
Fiscal Year End: March
Full Time Employees: 0
Back to stocks